Skip to main content
. 2021 Feb 22;14:479–493. doi: 10.2147/JIR.S292764

Figure 1.

Figure 1

NMN moderated decreased NAD+ status of CEC in HS status. (A) The detailed salvage pathway of NMN metabolism. n = 3. (B) The NAD+ content in control group, HS status and 125, 250 and 500 μM NMN-treated HS group. n = 3, data presented as mean ± SD. One-way ANOVA with SNK multiple comparisons test. *P<0.05, ***P<0.001. (C) The expression of TonEBP in control group, HS status and 125, 250 and 500 μM NMN-treated HS group. n = 3, data presented as mean ± SD. One-way ANOVA with SNK multiple comparisons test. *P<0.05, ***P<0.001.